NASDAQ: TRDA - Entrada Therapeutics, Inc.

Rentabilidad a seis meses: +44.28%
Sector: Healthcare

Calendario de promoción Entrada Therapeutics, Inc.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs.

Más detalles
The company's lead therapeutic candidates, which include ENTR-601-44 and ENTR-601-45, which are in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1; ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy; and ENTR-701, which is in preclinical trail for the treatment of myotonic dystrophy type 1. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

Цена ао 13.76
EBITDA -0.0117
Число акций ао 0.03305 млрд
P/BV 1.79
EV/EBITDA 1.44
ISIN US29384C1080
Сайт https://www.entradatx.com
Выручка 0.0253
P/S 18.67
Валюта usd
IPO date 2021-10-29
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Cambio de precio por día: 0% (17.53)
Cambio de precio por semana.: +8.41% (16.17)
Cambio de precio por mes: +16.87% (15)
Cambio de precio en 3 meses.: +3.85% (16.88)
Cambio de precio en seis meses: +44.28% (12.15)
Cambio de precio por año: +15.71% (15.15)
Cambio de precio desde principios de año.: +54.31% (11.36)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 4.28 4
P/BV 2.28 6
P/E 0 0
EV/EBITDA -1720.37 0
Total: 5

Eficiencia

Nombre Significado Calificación
ROA, % -1.42 0
ROE, % -2.76 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -212.55 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 410.74 10
Rentabilidad Ebitda, % -97.26 0
Rentabilidad EPS, % -43.91 0
Total: 3.2
Más detalles

Instituciones Volumen Compartir, %
Baker Brothers Advisors, LLC 4865819 14.48
Mpm Asset Management, LLC 4425784 13.17
5AM Venture Management, LLC 4408379 13.12
Price (T.Rowe) Associates Inc 3009673 8.96
Blackrock Inc. 1502537 4.47
Redmile Group, LLC 1283735 3.82
Vanguard Group Inc 1065166 3.17
Wellington Management Group, LLP 1047780 3.12
StepStone Group LP 761277 2.27
Tcg Crossover Management, Llc 584955 1.74

ETF Compartir, % Rentabilidad del año, % Dividendos, %
Avantis U.S Small Cap Equity ETF 0.04469 27.774101036841 1.68271
Avantis Responsible U.S. Equity ETF 0.00307 26.778312788906 1.45257
Avantis U.S. Equity ETF 0.00145 30.365392144069 1.59151
Avantis U.S. Small Cap Value ETF 0.00122 29.302558956347 2.3212
Dimensional U.S. Core Equity 2 ETF 0.00003 30.755198832543 1.47098
Dimensional U.S. Targeted Value ETF 0.00098 26.007247921552 1.93487
Dimensional US Core Equity Market ETF 0.00096 30.983243755928 1.40618
Dimensional US Small Cap Value ETF 0.00252 25.854782942758 1.97866
Dimensional U.S. Equity ETF 0.00027 31.530984204131 1.3557
WisdomTree U.S. SmallCap Fund 0.07886 29.467482438251 1.80258
First Trust Dow Jones Select MicroCap Index Fund 0.52221 26.184578018465 1.56612
Fidelity MSCI Health Care Index ETF 0.00401 16.20294599018 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05026 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00207 5.9237999659878 1.47892
iShares Neuroscience and Healthcare ETF 0.59012 19.720292847757 0.03
iShares Micro-Cap ETF 0.09211 34.327031588619 1.54048
iShares Russell 3000 ETF 0.00074 31.230028873917 1.43482
Nuveen ESG Small-Cap ETF 0.02399 27.987510644337 1.41019
Schwab U.S. Small-Cap ETF 0.00715 -34.641922436355 1.51433
Schwab U.S. Broad Market ETF 0.00046 -56.193181818182 1.43354
ProShares UltraPro Russell2000 0.00784 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 ETF 0.02 32.773459189339 1.48801



Supervisor Título profesional Pago año de nacimiento
Mr. Dipal Doshi CEO & Director 968.21k 1976 (48 años)
Mr. Nathan J. Dowden President & COO 694.3k 1971 (53 año)
Dr. Natarajan Sethuraman Ph.D. Chief Scientific Officer 694.3k 1962 (62 año)
Mr. Kory James Wentworth CPA CFO & Treasurer N/A 1979 (45 años)
Dr. Jared Cohen J.D., Ph.D. General Counsel N/A
Ms. Kerry Robert M.S. Senior Vice President of People N/A
Ms. Karla MacDonald Chief Corporate Affairs Officer N/A
Mr. Kevin Healy Ph.D. Senior Vice President of Regulatory Affairs N/A

DIRECCIÓN: United States, Boston. MA, 6 Tide Street - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.entradatx.com